drugset / Trial / NCT00296153
Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effect of Omacor 4g/day on blood lipid parameters and on the function and stiffness of blood vessels in HIV infected patients on Antiretroviral Therapy (HAART)
Timeline
- Start
- 2006-02
- Primary completion
- 2006-11
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omega-3-acid ethyl esters 90 | Unknown | 1000 mg | — |